Related Experiment Video
Updated: Jun 27, 2026

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
Prediction Models and Risk Factors for Steroid Resistance in Children with Nephrotic Syndrome: A Systematic Review
Yuanhui Hu1,2,3,4,5, Zehui Zhang5, Sha Diao1,2,3,4
1Department of Pharmacy/Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University, No. 20, Section 3, Renmin South Road, Wuhou District, Chengdu 610041, China.
Predictive models for pediatric steroid-resistant nephrotic syndrome (SRNS) show promise but suffer from high bias and limited validation. Future research needs rigorous development and external validation of these models to improve clinical use.
Area of Science:
- Pediatric Nephrology
- Clinical Epidemiology
Background:
- Steroid resistance in pediatric nephrotic syndrome (SRNS) is linked to poor prognosis.
- Predictive models and risk factors for SRNS are not well-established.
Purpose of the Study:
- To systematically review and meta-analyze studies developing SRNS prediction models.
- To identify risk factors associated with SRNS.
Main Methods:
- Comprehensive literature search across multiple databases (PubMed, Embase, etc.) up to March 2025.
- Random-effects meta-analysis of odds ratios and AUC for prediction models.
- Risk of bias assessment using PROBAST and Newcastle-Ottawa Scale.
Main Results:
- 23 studies were included from 2264 initially identified.
- Logistic regression was the primary method for model development (94.1%).
- Reported AUC for models ranged from 0.75 to 0.88, with limited external validation.
- 22 independent risk factors were identified, with five novel factors not previously included in models.
- Significant risk of bias was noted in 76% of model studies and 26% of risk factor analyses.
Conclusions:
- Current SRNS prediction models exhibit good discrimination but are limited by high risk of bias and insufficient external validation.
- Several important risk factors are not yet incorporated into existing models.
- Future research must focus on robust model development and multi-center external validation for clinical utility.
Related Concept Videos
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome III : Nursing Management
Pharmacokinetics in Pediatric Patients: Drug Excretion
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration